Search research articles
Contact Us
Filters
Showing results (21-30 of 134) with videos related to
Page
of 14
Sort By:
Translational Vision Science & Technology
|
March 17, 2017
Variability of Retinal Thickness Measurements in Tilted or Stretched Optical Coherence Tomography Images
Akihito Uji, Nizar Saleh Abdelfattah, David S Boyer, et al.
Ophthalmology. Retina
|
April 2, 2019
Effectiveness of Continued Ranibizumab Therapy in Neovascular Age-Related Macular Degeneration versus Switch to Aflibercept: Real World Evidence
Usha Chakravarthy, Vladimir Bezlyak, Alexandros Sagkriotis, et al.
Journal of Cataract and Refractive Surgery
|
January 31, 2012
Outcomes of cataract surgery in patients with neovascular age-related macular degeneration in the era of anti-vascular endothelial growth factor therapy
Homayoun Tabandeh, Nauman A Chaudhry, David S Boyer, et al.
Retina (Philadelphia, Pa.)
|
October 7, 2010
Anatomical benefit from ranibizumab treatment of predominantly classic neovascular age-related macular degeneration in the 2-year anchor study
Srinivas R Sadda, Glenn Stoller, David S Boyer, et al.
Journal of Glaucoma
|
November 19, 2013
Methyl-sulfonyl-methane (MSM)-induced acute angle closure
Jeremy C Hwang, Kay T Khine, Jennifer C Lee, et al.
Retina (Philadelphia, Pa.)
|
December 1, 2016
THE PATHOPHYSIOLOGY OF GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION AND THE COMPLEMENT PATHWAY AS A THERAPEUTIC TARGET
David S Boyer, Ursula Schmidt-Erfurth, Menno van Lookeren Campagne, et al.
American Journal of Ophthalmology
|
June 19, 2017
Postreceptor Neuronal Loss in Intermediate Age-related Macular Degeneration
Enrico Borrelli, Nizar Saleh Abdelfattah, Akihito Uji, et al.
Ophthalmology
|
March 27, 2012
Verteporfin plus ranibizumab for choroidal neovascularization in age-related macular degeneration: twelve-month results of the DENALI study
Peter K Kaiser, David S Boyer, Alan F Cruess, et al.
Eye (London, England)
|
May 28, 2024
ROBIN: a randomised, double-masked, placebo-controlled Phase IIa study of the AOC3 inhibitor BI 1467335 in diabetic retinopathy
Quan Dong Nguyen, Justis P Ehlers, David S Boyer, et al.
BMJ Open Ophthalmology
|
February 3, 2026
Safety and tolerability of avacincaptad pegol in combination with ranibizumab in treatment-naïve patients with neovascular age-related macular degeneration: results from a phase 1 and phase 2a study
Sunil S Patel, David S Boyer, Anat Loewenstein, et al.
Page
of 14
Search research articles
Search
Showing results (21-30 of 134) with videos related to
Sort By:
Page
of 14
Translational Vision Science & Technology
|
March 17, 2017
Variability of Retinal Thickness Measurements in Tilted or Stretched Optical Coherence Tomography Images
Akihito Uji, Nizar Saleh Abdelfattah, David S Boyer, et al.
Ophthalmology. Retina
|
April 2, 2019
Effectiveness of Continued Ranibizumab Therapy in Neovascular Age-Related Macular Degeneration versus Switch to Aflibercept: Real World Evidence
Usha Chakravarthy, Vladimir Bezlyak, Alexandros Sagkriotis, et al.
Journal of Cataract and Refractive Surgery
|
January 31, 2012
Outcomes of cataract surgery in patients with neovascular age-related macular degeneration in the era of anti-vascular endothelial growth factor therapy
Homayoun Tabandeh, Nauman A Chaudhry, David S Boyer, et al.
Retina (Philadelphia, Pa.)
|
October 7, 2010
Anatomical benefit from ranibizumab treatment of predominantly classic neovascular age-related macular degeneration in the 2-year anchor study
Srinivas R Sadda, Glenn Stoller, David S Boyer, et al.
Journal of Glaucoma
|
November 19, 2013
Methyl-sulfonyl-methane (MSM)-induced acute angle closure
Jeremy C Hwang, Kay T Khine, Jennifer C Lee, et al.
Retina (Philadelphia, Pa.)
|
December 1, 2016
THE PATHOPHYSIOLOGY OF GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION AND THE COMPLEMENT PATHWAY AS A THERAPEUTIC TARGET
David S Boyer, Ursula Schmidt-Erfurth, Menno van Lookeren Campagne, et al.
American Journal of Ophthalmology
|
June 19, 2017
Postreceptor Neuronal Loss in Intermediate Age-related Macular Degeneration
Enrico Borrelli, Nizar Saleh Abdelfattah, Akihito Uji, et al.
Ophthalmology
|
March 27, 2012
Verteporfin plus ranibizumab for choroidal neovascularization in age-related macular degeneration: twelve-month results of the DENALI study
Peter K Kaiser, David S Boyer, Alan F Cruess, et al.
Eye (London, England)
|
May 28, 2024
ROBIN: a randomised, double-masked, placebo-controlled Phase IIa study of the AOC3 inhibitor BI 1467335 in diabetic retinopathy
Quan Dong Nguyen, Justis P Ehlers, David S Boyer, et al.
BMJ Open Ophthalmology
|
February 3, 2026
Safety and tolerability of avacincaptad pegol in combination with ranibizumab in treatment-naïve patients with neovascular age-related macular degeneration: results from a phase 1 and phase 2a study
Sunil S Patel, David S Boyer, Anat Loewenstein, et al.
Page
of 14